397 related articles for article (PubMed ID: 34088771)
1. Comparing Semiquantitative and Qualitative Methods of Vascular
Dashora HR; Rosenblum JS; Quinn KA; Alessi H; Novakovich E; Saboury B; Ahlman MA; Grayson PC
J Nucl Med; 2022 Feb; 63(2):280-286. PubMed ID: 34088771
[TBL] [Abstract][Full Text] [Related]
2.
Grayson PC; Alehashemi S; Bagheri AA; Civelek AC; Cupps TR; Kaplan MJ; Malayeri AA; Merkel PA; Novakovich E; Bluemke DA; Ahlman MA
Arthritis Rheumatol; 2018 Mar; 70(3):439-449. PubMed ID: 29145713
[TBL] [Abstract][Full Text] [Related]
3. Use of 18F-fluorodeoxyglucose positron emission tomography to monitor tocilizumab effect on vascular inflammation in giant cell arteritis.
Quinn KA; Dashora H; Novakovich E; Ahlman MA; Grayson PC
Rheumatology (Oxford); 2021 Sep; 60(9):4384-4389. PubMed ID: 33369678
[TBL] [Abstract][Full Text] [Related]
4. Association of
Quinn KA; Ahlman MA; Alessi HD; LaValley MP; Neogi T; Marko J; Novakovich E; Grayson PC
Arthritis Rheumatol; 2023 Jan; 75(1):98-107. PubMed ID: 35792044
[TBL] [Abstract][Full Text] [Related]
5. Assessment of Takayasu arteritis in routine practice with PETVAS, an 18F-FDG PET quantitative scoring tool.
Tahra SK; Özgüven S; Ünal AU; Öner FA; Öneş T; Erdil TY; Direskeneli H
Turk J Med Sci; 2022 Apr; 52(2):313-322. PubMed ID: 36161613
[TBL] [Abstract][Full Text] [Related]
6. Metabolic inflammatory volume and total inflammatory glycolysis: novel parameters to evaluate PET-CT disease activity in Takayasu arteritis.
Ora M; Misra DP; Kavadichanda CG; Singh K; Rathore U; Jain N; Agarwal V; Gambhir S
Clin Rheumatol; 2023 Jul; 42(7):1855-1861. PubMed ID: 37055597
[TBL] [Abstract][Full Text] [Related]
7. The utility of fluorine-18-fluorodeoxyglucose positron emission tomography in the diagnosis and monitoring of large vessel vasculitis: A South Australian retrospective audit.
Nguyen AD; Crowhurst T; Lester S; Dobson R; Bartholomeusz D; Hill C
Int J Rheum Dis; 2019 Aug; 22(8):1378-1382. PubMed ID: 31211510
[TBL] [Abstract][Full Text] [Related]
8. The role of (18) F-fluorodeoxyglucose-positron emission tomography in the assessment of disease activity in patients with takayasu arteritis.
Lee KH; Cho A; Choi YJ; Lee SW; Ha YJ; Jung SJ; Park MC; Lee JD; Lee SK; Park YB
Arthritis Rheum; 2012 Mar; 64(3):866-75. PubMed ID: 21989701
[TBL] [Abstract][Full Text] [Related]
9. [(18)F]fluorodeoxyglucose PET in large vessel vasculitis.
Walter MA
Radiol Clin North Am; 2007 Jul; 45(4):735-44, viii. PubMed ID: 17706537
[TBL] [Abstract][Full Text] [Related]
10. Imaging giant cell arteritis and Aortitis in contrast enhanced 18F-FDG PET/CT: Which imaging score correlates best with laboratory inflammation markers?
Olthof SC; Krumm P; Henes J; Nikolaou K; la Fougère C; Pfannenberg C; Schwenzer N
Eur J Radiol; 2018 Feb; 99():94-102. PubMed ID: 29362158
[TBL] [Abstract][Full Text] [Related]
11. The value of [18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease.
Walter MA; Melzer RA; Schindler C; Müller-Brand J; Tyndall A; Nitzsche EU
Eur J Nucl Med Mol Imaging; 2005 Jun; 32(6):674-81. PubMed ID: 15747154
[TBL] [Abstract][Full Text] [Related]
12. The role of PET/CT in disease activity assessment in patients with large vessel vasculitis.
Galli E; Muratore F; Mancuso P; Boiardi L; Marvisi C; Besutti G; Spaggiari L; Casali M; Versari A; Giorgi Rossi P; Salvarani C
Rheumatology (Oxford); 2022 Nov; 61(12):4809-4816. PubMed ID: 35258570
[TBL] [Abstract][Full Text] [Related]
13. Imaging features of
Chen Z; Zhao Y; Wang Q; Li Y; Li H; Zhou Y
Clin Rheumatol; 2022 May; 41(5):1499-1509. PubMed ID: 35088208
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal Characterization of Vascular Inflammation and Disease Activity in Takayasu Arteritis and Giant Cell Arteritis: A Single-Center Prospective Study.
Alessi HD; Quinn KA; Ahlman MA; Novakovich E; Saboury B; Luo Y; Grayson PC
Arthritis Care Res (Hoboken); 2023 Jun; 75(6):1362-1370. PubMed ID: 35762866
[TBL] [Abstract][Full Text] [Related]
15. Different Scoring Methods of FDG PET/CT in Giant Cell Arteritis: Need for Standardization.
Stellingwerff MD; Brouwer E; Lensen KDF; Rutgers A; Arends S; van der Geest KSM; Glaudemans AWJM; Slart RHJA
Medicine (Baltimore); 2015 Sep; 94(37):e1542. PubMed ID: 26376404
[TBL] [Abstract][Full Text] [Related]
16. Aortic wall inflammation due to Takayasu arteritis imaged with 18F-FDG PET coregistered with enhanced CT.
Kobayashi Y; Ishii K; Oda K; Nariai T; Tanaka Y; Ishiwata K; Numano F
J Nucl Med; 2005 Jun; 46(6):917-22. PubMed ID: 15937300
[TBL] [Abstract][Full Text] [Related]
17. Visual and semiquantitative assessment of cranial artery inflammation with FDG-PET/CT in giant cell arteritis.
Nienhuis PH; Sandovici M; Glaudemans AW; Slart RH; Brouwer E
Semin Arthritis Rheum; 2020 Aug; 50(4):616-623. PubMed ID: 32502725
[TBL] [Abstract][Full Text] [Related]
18. Effect of Treatment on Imaging, Clinical, and Serologic Assessments of Disease Activity in Large-vessel Vasculitis.
Banerjee S; Quinn KA; Gribbons KB; Rosenblum JS; Civelek AC; Novakovich E; Merkel PA; Ahlman MA; Grayson PC
J Rheumatol; 2020 Jan; 47(1):99-107. PubMed ID: 30877209
[TBL] [Abstract][Full Text] [Related]
19. Development of a simple standardized scoring system for assessing large vessel vasculitis by 18F-FDG PET-CT and differentiation from atherosclerosis.
Bacour YAA; van Kanten MP; Smit F; Comans EFI; Akarriou M; de Vet HCW; Voskuyl AE; van der Laken CJ; Smulders YM
Eur J Nucl Med Mol Imaging; 2023 Jul; 50(9):2647-2655. PubMed ID: 37115211
[TBL] [Abstract][Full Text] [Related]
20. The role of PET/CT in disease activity assessment in patients with large vessel vasculitis.
Galli E; Pipitone N; Salvarani C
Curr Opin Rheumatol; 2023 May; 35(3):194-200. PubMed ID: 36866659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
